The Impact of COVID-19 on Brain Stimulation Therapy - 24/02/22
Doi : 10.1016/j.psc.2021.11.008
Michael Justin Coffey, MD a, ⁎ 
, Suzanne Kerns, MBBS b, Sohag Sanghani, MD c, Lee Wachtel, MD d
, Suzanne Kerns, MBBS b, Sohag Sanghani, MD c, Lee Wachtel, MD d a Geisinger Health System, 100 N Academy Ave, Danville, PA 17822, USA
b Medical University of South Carolina, Charleston, SC, USA
c Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
d Kennedy Krieger Institute, Baltimore, MD, USA
∗Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Résumé |
Among the far-reaching effects of the COVID-19 pandemic has been restricted access to safe and effective forms of psychiatric treatment. Focusing on electroconvulsive therapy and transcranial magnetic stimulation, we review the pandemic's impact on brain stimulation therapy by asking 3 fundamental questions—Where have we been? How are we doing? And where are we going?
Le texte complet de cet article est disponible en PDF.Keywords : Electroconvulsive therapy (ECT), Transcranial magnetic stimulation (TMS), Brain stimulation, COVID-19, Access to care
Plan
© 2021
Elsevier Inc. Tous droits réservés.
Vol 45 - N° 1
P. 123-131 - mars 2022 Retour au numéro
Article précédent
- Impact of COVID-19 on Mental Health Care Practitioners
- Peter Yellowlees
- Impact on Child Psychiatry
- Shireen F. Cama, Brigitta E. Miyamoto, Sandra M. DeJong
Bienvenue sur EM-consulte, la référence des professionnels de santé.